Examinando por Autor "López-Jaramillo, Patricio"
Mostrando 1 - 4 de 4
Resultados por página
Opciones de ordenación
Ítem Guidelines on themanagement of arterial hypertension and related comorbidities in Latin America(International Society of Hypertension, 2017) Burlando, Guillermo; Gonzalez, Claudio; Piskorz, Daniel; Ramirez, Agustín J.; Sanchez, Ramiro A.; Simsolo, Rosa; Voto, Liliana; Alessi, Alexandre; Amodeo, Celso; Araujo Brandáo, Andrea; Baiocchi, Sergio; Barbosa, Eduardo; Barreto Filho, José Augusto; Brandaó Veiga, Paulo César; Brasil, David; Dischinger Miranda, Roberto; Fritsch, Mario; Kalil, Marcio; Machado, Carlos Alberto; Magalhaés Feitosa, Audes; Bolivar Malachias, Marcus Vinicius; Malta, Deborah; Decio Mion, Jr.; Moreno, Heitor; Mota Gomes, Marco; Nobre, Fernando; Nogueira, Armando; Oigman, Wille; Passarelli Jr., Oswaldo; Ribeiro, José Márcio; Santos Póvoa, Rui Manoel; Schmid, Helena; Sebba Barroso, Weimar Kunz; Veiga Jardim, Thiago; Vilela-Martin, José Fernando; Cobos, Leonardo; Lanas, Fernando; Villar Moya, Raul; Accini Mendoza, José Luis; Garcia-Ortiz, Luis Hernando; López-Jaramillo, Patricio; Molina, Dora Ines; Sanchez, Gregorio; Urina – Triana, Miguel; Morales-Salinas, Alberto; Lara, Joffre; Stuardo Wyss, Fernando; Alcocer, Luis; Gonzalez Caamanó, Angel; Parra-Carrillo, Jose Z.; Ortellado, José; Bryce Moncloa, Alfonso; Senclen Santisteban, Segundo; Diaz, Margarita E.; Hernandez Hernandez, Rafael; Lopez, Jesús; Machado, Livia T.; Ponte-Negretti, CarlosABI, ankle-brachial index; ABPM, ambulatory blood pressure monitoring; ACCORD, Action to Control Cardiovascular Risk in Diabetes; ACE-I, angiotensin-converting-enzyme-inhibitors; ARB, AT1 blockers; BP, blood pressure; CARMELA, Cardiovascular Risk Factor Multiple Evaluation in Latin America; CARMEN, Community Actions for Multifactorial Reduction of Non- Communicable Diseases; CCB, calcium channel blocker; CCM, Wagner’s Chronic Care Model; CDC, Chronic Disease Center; CTA, computed tomography angiography; CV, cardiovascular; DALY, disability-adjusted life year; DPP- 4, dipeptidyl-peptidase-4; GLP-1, glucagon-like peptide 1; HBPM, home blood pressure monitoring; HOPE, Heart Outcomes Prevention Evaluation; HOT, Hypertension Optimal Treatment; HT, hypertension; LA, Latin America; LASH, Latin American Society of Hypertension; MRA, magnetic resonance angiography; NCD, noncommunicable disease; OSAS, obstructive apnea–hypopnea syndrome; PAD, peripheral artery disease; PAHO, Pan American Health Organization; RAAS, renin–angiotensin–aldosterone system; RISS, Redes Integradas de Servicios de Salud; SGLUT2, sodium–glucose cotransporter-2; SPRINT, SBP Intervention Trial; UKPDS, United Kingdom Prospective Diabetes Study; VIDA, Veracruz Initiative for Diabetes AwarenessÍtem Handgrip strength Is associated with specific aspects of vascular function in individuals with metabolic syndrome(MDPI, 2023) Sánchez-Delgado, Juan Carlos; Cohen, Daniel D.; Camacho-López, Paul A.; Carreño-Robayo, Javier; Castañeda-Hernández, Álvaro; García-González, Daniel; Martínez-Bello, Daniel; Aroca-Martínez, Gustavo; Parati, Gianfranco; López-Jaramillo, PatricioBackground: Metabolic syndrome (MetS) is a disorder associated with an increased risk for the development of diabetes mellitus and its complications. Lower isometric handgrip strength (HGS) is associated with an increased risk of cardiometabolic diseases. However, the association between HGS and arterial stiffness parameters, which are considered the predictors of morbidity and mortality in individuals with MetS, is not well defined. Objective: To determine the association between HGS and HGS asymmetry on components of vascular function in adults with MetS. Methods: We measured handgrip strength normalized to bodyweight (HGS/kg), HGS asymmetry, body composition, blood glucose, lipid profile, blood pressure, pulse wave velocity (PWV), reflection coefficient (RC), augmentation index @75 bpm (AIx@75) and peripheral vascular resistance (PVR) in 55 adults with a diagnosis of MetS between 25 and 54 years old. Results: Mean age was 43.1 7.0 years, 56.3% were females. HGS/kg was negatively correlated with AIx@75 (r = -0.440), p < 0.05, but these associations were not significant after adjusting for age and sex. However, when interaction effects between sex, HGS/kg and age were examined, we observed an inverse relationship between HGS/kg and AIx@75 in the older adults in the sample, whereas in the younger adults, a weak direct association was found. We also found a significant association between HGS asymmetry and PVR (beta = 30, 95% CI = 7.02; 54.2; p <0.012). Conclusions: Our findings suggest that in people with MetS, maintaining muscle strength may have an increasingly important role in older age in the attenuation of age-related increases in AIx@75—a marker of vascular stiffness—and that a higher HGS asymmetry could be associated with a greater vascular resistance.Ítem Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE)(Permanyer, 2021) Ponte-Negretti, Carlos I.; S. Wyss, Fernando; Piskorz, Daniel; D Santos, Raul; Villar, Raul; Lorenzatti, Alberto; López-Jaramillo, Patricio; Toth, Peter; J. Amaro, A. Juan; Rodrigo, Alfonso K.; Lanas, Fernando; Urina-Triana, Miguel; Lara, Jofre; Valdés, T. Osiris; Gomez-Mancebo, José R.; Bryce, Alfonso; Cobos S, Leonardo; Puente-Barragan, Adriana; Ullauri-Solórzano, Vladimir E.; Medina-Palomino, Felix A.; Lozada, Alfredo F.; Duran, Maritza; Berrospi, Percy; Miranda, David; Badimon, Juan J.; R. González, J. José; Libby, PeterHypertension, hyperglycemia, dyslipidemia, overweight, obesity, and tobacco (smoking, chewing, and vaping), together with a pro-inflammatory and procoagulant state, are the main risk factors related to atherosclerotic cardiovascular disease. Objective and methods: A group of experts from the Americas, based on their clinical expertise in cardiology, cardiovascular prevention, and cardiometabolic (CM) diseases, joined together to develop these practical recommendations for the optimal evaluation and treatment of residual CM risk factors in Latin America, using a modified Delphi methodology (details in electronic TSI) to generate a comprehensive CM risk reduction guideline, and through personalized medicine and patient-centered decision, considering the cost-benefit ratio The process was well defined to avoid conflicts of interest that could bias the discussion and recommendations. Results: Residual risk reduction should consider therapeutic options adapt- ed to specific patient needs, based on five treatment objectives: triglyceride-rich lipoproteins, inflammation, impaired glucose metabolism, high blood pressure, and prothrombotic status. Comprehensive control of all CM risk factors should be a priority to deal with this important public health problem and prevent premature deaths. The recommendations in this paper address the evidence-based treatment of CM risk and are intended for clinical application in Latin American countries.Ítem Reductions in systolic blood pressure achieved by hypertensiveswith three isometric training sessions perweek aremaintainedwith a single session perweek(Wiley Online Library, 2023) Cohen, Daniel D.; Aroca-Martínez, Gustavo; Carreño-Robayo, Javier; Castañeda-Hernández, Álvaro; Herazo-Beltrán, Yaneth; Camacho, Paul A.; Otero, Johanna; Martínez-Bello, Daniel; Lopez-Lopez, José P.; López-Jaramillo, PatricioIsometric handgrip or (wall) squat exercise performed three times per week produces reductions in systolic blood pressure (SBP) in adults with hypertension. We aimed to compare these interventions and the potential to retain benefits with one exercise session per week. We compared blood pressure changes following handgrip and squat isometric training interventions with controls in a randomized controlled multicentre trial in 77 unmedicated hypertensive (SBP ≥ 130 mmHg) adults. Exercise sessions were performed in the workplace and consisted of four repetitions—three sessions per week for the first 12 weeks (phase 1), and one session per week for the subsequent 12 weeks (phase 2). Office blood pressure (BP) was measured at baseline, post-phase 1 and post-phase 2. Post-phase 1, mean reductions in SBP were significantly greater in handgrip (–11.2 mmHg, n = 28) and squat (–12.9 mmHg, n = 27) groups than in controls (–.4 mmHg; n = 22) but changes in DBP were not. There were no significant within-group changes during phase 2 but SBP was 3.8 mmHg lower in the wall squat than the handgrip group—a small magnitude but clinically important difference. While both interventions produced significant SBP reductions, the wall squat appears to be more effective in maintaining benefits with a minimal training dose. The low time investment to achieve and retain clinically significant SBP reductions—42 and 12 min, respectively—and minimal cost, particularly of the wall squat, make it a promising intervention for delivery in public health settings.